EMERYVILLE, Calif., May 29 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. , today announced that Craig W. Carlson, Vice President and Chief Financial Officer, will present at Dutton Associates' "Recognizing Opportunity" SmallCap Conference at 10:50 am on May 30, 2007 at the Omni Hotel in San Francisco.
The 30-minute presentation will be followed by a short webcast and a 30-minute breakout session in the afternoon. Mr. Carlson will be available to meet with informal groups of investment professionals during one-on-one scheduled meetings. The webcast will be available live on May 30, 2007 and is available at the following link: http://www.shareholder.com/ntii/calendar.cfm
About Neurobiological Technologies, Inc.
NTI is a biotechnology company engaged in the business of acquiring and developing central nervous system related drug candidates. The Company is focused on therapies for neurological conditions that occur in connection with ischemic stroke and brain cancer. The Company's strategy is to in-license and develop later-stage drug candidates that target major medical needs and that can be rapidly commercialized. NTI's experienced management team oversees the human clinical trials necessary to establish preliminary evidence of efficacy.
Neurobiological Technologies, Inc.CONTACT: Craig W. Carlson, VP & CFO of Neurobiological Technologies, Inc.,+1-510-595-6000
Web site: http://www.ntii.com/
